Pharmacotherapy Update 2021 Webcast

The pharmacotherapy Update 2021 Webcast is organized by AchieveCE.

Activity Release Date: April 12, 2022
Activity Expiration Date: April 12, 2025

Activity Overview:
The FDA has increased the number of medication approvals exponentially over the past 10 years. In 2020, 53 new drugs and biologics were approved as compared to 48 in 2019. Of the ones approved last year, 40% were first in class, and 58% received indications to manage rare diseases.

This CE addresses approximately 35 of the new medications approved in 2020 that the average pharmacist may not have had time to review and keep track of as they entered the market. This presentation will address this gap and focus on medications used primarily in Ambulatory Care and Community practice settings. The information is centred not only on how the medications work but also includes clinical trial summaries that led to their approval by the FDA which will be discussed in relation to current EBM guidelines and treatment algorithms.

Pharmacist Learning Objectives:
At the conclusion of this continuing education activity, the participant will be able to:
• Identify the new pharmaceutical agents available for clinical practice
• Outline the use of new pharmaceutical agents in clinical practice
• Explain the benefits, risks, and alternatives of new pharmaceutical agents

Pharmacy Technician Learning Objectives:
At the conclusion of this continuing education activity, the participant will be able to:
• Identify the new pharmaceutical agents available for clinical practice
• Outline the use of new pharmaceutical agents in clinical practice
• Explain the benefits, risks, and alternatives of new pharmaceutical agents

Nurse Learning Objectives:
At the conclusion of this continuing education activity, the participant will be able to:
• Identify the new pharmaceutical agents available for clinical practice
• Outline the use of new pharmaceutical agents in clinical practice
• Explain the benefits, risks, and alternatives of new pharmaceutical agents.